The Malaysian bank continues to expand its product offering to tap overseas markets.
Kenanga Investment Bank Berhad launched the world's first structured warrants tied to the Hang Seng Biotech Index (HSBIO) this month. The timing is significant. HSBIO gained 64% in 2025 and approximately 98% over the two years to 31 August 2026 - Philip Lim, Kenanga Investment Bank Berhad The roll out marks the bank's continuous expansion in the overseas markets, following the introduction of a series of Hang Seng Index structured warrants, including Hang Seng China Enterprises In